A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 35,400 shares of AURA stock, worth $394,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,400
Previous 31,500 12.38%
Holding current value
$394,356
Previous $247,000 8.1%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.81 - $7.89 $26,559 - $30,771
3,900 Added 12.38%
35,400 $267,000
Q1 2024

May 15, 2024

BUY
$7.09 - $9.24 $223,335 - $291,060
31,500 New
31,500 $247,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $326M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.